Evidence map›Paper›PMID 42745613›Full record

ArticleCanadian respiratory journal2026

Clinical Characteristics of Mycoplasma pneumoniae Pneumonia in Children and Risk Factors for Progression to Severe Disease.

Chao Fu, Xiang He, Chengcheng Li, Shirong Luo, Yunrong Li

Abstract read
In one paragraph

Article in Canadian respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chao FuThe First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi Guizhou, 563000, China.ORCID https://orcid.org/0009-0008-0903-5409
Xiang HeThe First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi Guizhou, 563000, China.
Chengcheng LiThe First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi Guizhou, 563000, China.
Shirong LuoThe First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi Guizhou, 563000, China.
Yunrong LiThe First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi Guizhou, 563000, China.

Funding

Science and Technology Fund of Guizhou Provincial Health Commission gzwkj2024-429
6 · The paper itself

Abstract

objectiveTo understand the clinical characteristics of severe and nonsevere Mycoplasma pneumoniae pneumonia (MPP) in children and analyze the risk factors for severe Mycoplasma pneumoniae pneumonia (SMPP), providing a basis for early clinical diagnosis and treatment of SMPP.

methodsA retrospective analysis was conducted on 146 children with MPP admitted to pediatric wards 1-4 of Zunyi First People's Hospital from August 2024 to June 2025. According to the severity of their condition, the patients were divided into a severe group (n = 49) and a nonsevere group (n = 97). Clinical manifestations, imaging data, and laboratory indicators were compared between the two groups, and logistic regression analysis was used to summarize the risk factors for pediatric SMPP.

results(1) The duration of fever and cough was significantly longer in the severe MPP group than in the nonsevere group (p < 0.05). Compared with those in the nonsevere group, instances of prematurity, intrauterine infection at birth, pulmonary consolidation, pleural effusion, high fever, wheezing, and difficulty breathing were significantly more frequent in the severe group (p < 0.05). (2) Laboratory indicators, such as C-reactive protein levels, lactate dehydrogenase levels, D-dimer levels, ferritin levels, the neutrophil ratio, and serum amyloid A levels, were significantly greater in the severe group than in the nonsevere group (p < 0.05). (3) The risk factors for SMPP included prematurity (OR = 4.747; 95% CI: 1.259 ∼ 17.891; p = 0.021), pulmonary consolidation (OR = 5.277; 95% CI: 1.372 ∼ 20.301; p = 0.016), high fever (OR = 25.597; 95% CI: 6.760 ∼ 96.926; p < 0.001), wheezing (OR = 6.913; 95% CI: 1.837 ∼ 26.017; p = 0.004), and difficulty breathing (OR = 5.990; 95% CI: 1.451 ∼ 24.722; p = 0.013).

conclusionChildren with SMPP have prolonged fever and cough, more severe clinical symptoms, and significantly elevated inflammation-related laboratory indicators. Prematurity, pulmonary consolidation, high fever, wheezing, and difficulty breathing are easily accessible baseline warning indicators for early identification of children at high risk of progression to SMPP. Strengthening early recognition and timely intervention in patients presenting with these factors may help optimize clinical management and improve outcomes.

Indexed as

Pneumonia, MycoplasmaChildChild, PreschoolChinaCoughC-Reactive ProteinDisease ProgressionFemaleFeverFibrin Fibrinogen Degradation ProductsHumansInfantL-Lactate DehydrogenaseMaleMycoplasma pneumoniaeRetrospective StudiesC-Reactive ProteinFibrin Fibrinogen Degradation ProductsL-Lactate DehydrogenasechildrenMycoplasma pneumoniaepneumoniarisk factorssevere

Identifiers

PMID42745613
PMCPMC13579244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.